Related Experiment Video

Updated: Oct 15, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K

The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives

Michele Fiore1, Andrea Sambri2,3, Paolo Spinnato4

  • 1Alma Mater Studiorum - University of Bologna, Bologna, Italy.

Current Treatment Options in Oncology
|October 23, 2021
PubMed
Abstract

Insights

Advancements in synovial sarcoma (SS) research reveal new diagnostic and therapeutic targets by exploring epigenomics and gene regulation. Further investigation is crucial to improve patient survival, as current treatments have limited impact.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Synovial sarcoma (SS) research is yielding new molecular insights.
  • Epigenomics and gene regulation present promising avenues for understanding SS pathogenesis.
  • Disruption of epigenomic regulatory complexes may underlie SS development.

Purpose of the Study:

  • To highlight emerging molecular insights in synovial sarcoma.
  • To discuss the potential of epigenomic research for diagnostic and therapeutic advancements.
  • To underscore the need for improved treatment strategies in SS.

Main Methods:

  • Review of current research on synovial sarcoma epigenomics and gene regulation.
  • Analysis of standard-of-care treatments and their limitations.
  • Identification of potential drug targets.

Main Results:

  • New molecular insights are emerging in synovial sarcoma.
  • Epigenomic research offers potential for novel biomarkers and therapeutic targets.
  • Current cytotoxic chemotherapy has limitations and side effects.

Conclusions:

  • Understanding epigenomic dysregulation in SS opens new perspectives.
  • Improved therapeutic strategies are urgently needed to enhance patient survival.
  • Continued research is essential for advancing synovial sarcoma treatment and outcomes.
Keywords:
Sarcoma epigenomicsSynovial sarcoma diagnosisSynovial sarcoma genomicsSynovial sarcoma treatment

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.3K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.2K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
1.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
736
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K